BAGELLA, Luigi Marco
 Distribuzione geografica
Continente #
NA - Nord America 1270
EU - Europa 833
AS - Asia 356
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
SA - Sud America 3
Totale 2476
Nazione #
US - Stati Uniti d'America 1260
UA - Ucraina 397
CN - Cina 316
DE - Germania 136
SE - Svezia 115
IT - Italia 67
FI - Finlandia 59
GB - Regno Unito 29
TR - Turchia 15
BE - Belgio 12
IN - India 9
IR - Iran 9
CA - Canada 8
AU - Australia 6
EU - Europa 6
FR - Francia 6
RO - Romania 5
ES - Italia 3
PT - Portogallo 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
CL - Cile 1
HK - Hong Kong 1
IM - Isola di Man 1
JP - Giappone 1
LK - Sri Lanka 1
MS - Montserrat 1
MX - Messico 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 2476
Città #
Chandler 486
Jacksonville 242
Princeton 150
Nanjing 105
Dearborn 76
Wilmington 55
Ann Arbor 49
Nanchang 47
Sassari 43
Beijing 33
Boardman 30
Woodbridge 29
Shenyang 20
Hebei 19
Changsha 14
Tianjin 14
Izmir 13
Norwalk 13
San Mateo 12
Andover 11
Brussels 11
Augusta 10
Leawood 10
Ningbo 10
Ardabil 8
Jinan 8
Monmouth Junction 8
San Francisco 8
Toronto 8
Lanzhou 7
Jiaxing 6
Kunming 6
Zhengzhou 6
Auburn Hills 5
Guangzhou 5
Hangzhou 4
Helsinki 4
Nuoro 4
Exton 3
Haikou 3
Philadelphia 3
Taizhou 3
Changchun 2
Chicago 2
Huskvarna 2
Lansdale 2
Madrid 2
Mumbai 2
Redwood City 2
Sydney 2
Albiate 1
Ashburn 1
Auckland 1
Barcelona 1
Bari 1
Beaverton 1
Bratislava 1
Cagliari 1
Canberra 1
Central 1
Colombo 1
Douglas 1
Drancy 1
Easton 1
Frankfurt am Main 1
Fuzhou 1
Houston 1
Las Vegas 1
Laurel 1
Leipzig 1
Leuven 1
Lincoln 1
Los Angeles 1
Melbourne 1
Mexico City 1
Paris 1
Pisa 1
Pittsburgh 1
Quartucciu 1
Redmond 1
Riyadh 1
Sabz 1
Shaoxing 1
Sinnai 1
São Paulo 1
Taipei 1
Taiyuan 1
Tokyo 1
Torino 1
Walnut 1
Totale 1657
Nome #
Anti-senescence efficacy of radio-electric asymmetric conveyer technology 60
Sputum analysis: non-invasive early lung cancer detection 60
Chemical synthesis structural features and biological activity of novel mammalian antibiotic peptides identified throw amplification of homologous cDNA sequences 56
CTCF and BORIS Regulate Rb2/p130 Gene Transcription: A Novel Mechanism and a New Paradigm for Understanding the Biology of Lung Cancer 53
Amniotic fluid stem cells morph into a cardiovascular lineage: analysis of a chemically induced cardiac and vascular commitment 52
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 51
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 50
EZH2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A 50
Activation of MyoD-dependent transcription by cdk9/cyclin T2 48
Frequent loss of Rb2/p130 in human ovarian carcinoma 47
Roles of enhancer of zeste homolog 2: From skeletal muscle differentiation to rhadbomyosarcoma carcinogenesis. 46
Activation and function of murine Cyclin T2A and Cyclin T2B during skeletal muscle differentiation. 46
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 45
Evaluation of EZH2 expression in hepatitis B patients 45
From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway 45
pRb2/p130 has an anti-apoptotic effect on apoptosis triggered by camptothecin and doxorubicin, and not by taxol 44
SFK Inhibitors as New Strategy for RMS Treatment 42
The BRG1 ATPase of chromatin remodelling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways 42
Viral infections as a cause of cancer 41
Physical interaction between pRb and cdk9/cyclinT2 complex 41
Biological characterization of two novel chathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities 41
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements 41
cDNA sequences of three sheep myeloid cathelicidins 40
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells 40
Activation and function of cyclin T/Cdk9 (positive transcription elongation factor-b) in cardiac muscle cell hypertrophy 39
Long noncoding RNA SYISL: the crucial interaction with EZH2 in skeletal muscle differentiation and disorders 39
Biological Activity of a Novel, Cathelicidin-derived Antimicrobial Peptide from Sheep 38
Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy 38
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 38
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment 37
The Retinoblastoma gene family pRb/p105, p107, pRb2/p130 and Simian Virus-40 Large-T antigen in human mesotheliomas 37
The COOH-terminal Region of pRb2/p130 Binds to Histone Deacetilase 1 (HDAC1), Enhancing Transcriptional Repression of the E2F-dependent Cyclin A Promoter 37
A promyelocytic leukemia protein-thrombospondin-2 axis and the risk of relapse in neuroblastoma 37
A unique domain of pRb2/p130 acts as an inhibitor of cdk2 kinase activity 37
Frequent loss of pRb2/p130 in human ovarian carcinoma 36
MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions 35
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 35
Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. 35
Independent prognostic role of p16 expression in lung cancer 34
Roscovitine (Seliciclib, cyc202) prevents Cyclin A1 DNA damage induced up-regulation and reduces Double Strand Break (DSB) repair through NHEJ impairment. 34
Genomic Organization, Promoter Analysis, and Chromosomal Mapping of the Mouse Gene Encoding Cdk9 33
“The Retinoblastoma Family Protein p130 as a Negative Regulator of Cell Growth and Tumor Progression” 33
Study of viral integration of HPV-16 in young patients with LSIL 33
Cyclin E and Chromosome Instability (CIN) in colorectal cancer cell lines 33
A new parameter of growth inhibition for cell proliferation assays 33
Cdk9-55: a new player in muscle regeneration 33
Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300 32
Cloning of murine CDK9/PITALRE and its tissue-specific expression in development 32
Molecular cloning, expression and developmental characterization of the murine Retinoblastoma-related gene Rb2/p130 31
Preliminary study in early lung cancer detection using sputum sample 31
A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity and cell cycle arrest 31
Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy 31
Phisical Interacton between cdk9 and B-Myb results in suppression of B-Myb gene autoregulation 30
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma 30
Role of Enhancer of Zeste Homolog 2 Polycomb Protein and Its Significance in Tumor Progression and Cell Differentiation 28
Tet1 and Tdg suppress intestinal tumorigenesis by downregulating the inflammatory and immune responses in the Apc(Min)mouse model 28
Interaction Between the Cdk2/Cyclin A Complex and a Small Molecule Derived from the pRb2/p130 Spacer Domain: A Theoretical Model 28
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. 28
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1 27
Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle 26
Cytometry and DNA Ploidy: Clinical Uses and Molecular Perspective in Gastric and Lung Cancer 26
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors 23
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 22
BET-inhibitor I-BET762 and PARP-inhibitor talazoparib synergy in small cell lung cancer cells 19
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 19
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 18
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis 17
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 14
PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis 13
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment 13
Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 11
Silver nanoparticles derived by artemisia arborescens reveal anticancer and apoptosis-inducing effects 9
Tomentosin a Sesquiterpene Lactone Induces Antiproliferative and Proapoptotic Effects in Human Burkitt Lymphoma by Deregulation of Anti- and Pro-Apoptotic Genes 9
Role of enhancer of zeste homolog 2 polycomb protein and its significance in tumor progression and cell differentiation 8
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 6
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors 6
Totale 2556
Categoria #
all - tutte 5549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5549

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201844 0000 00 021 130010
2018/2019216 3730 2794 254 18341
2019/2020635 1611558 6167 1184 6722701
2020/2021552 661824 6321 721 76777712
2021/2022379 46228 27 1335 293437164
2022/2023613 798918172 87164 40 0000
Totale 2556